http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2756941-B2
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4418 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-275 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-58 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-73 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-135 |
| filingDate | 1996-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 1998-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 1998-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2756941-B2 |
| titleOfInvention | Use of 2-chloro-3-arylamino-1,4-naphthoquinone derivatives as platelet aggregation inhibitors |
| priorityDate | 1996-01-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 138.